Clinical trial / 2014
Higher dietary polyphenol consumption was linked to lower all-cause mortality in high-risk individuals.
Investigators examined data from 7,447 participants in the PREDIMED trial followed for an average of 4.8 years, recording 327 deaths. Comparing the highest to lowest quintiles of total polyphenol intake was linked to a reduced risk of all-cause mortality (HR 0.63; 95% CI 0.41 to 0.97; P for trend = 0.12). Among subclasses, stilbenes (HR 0.48; 95% CI 0.25 to 0.91) and lignans (HR 0.60; 95% CI 0.37 to 0.97) were inversely associated with mortality.
- Study type
- Secondary analysis of a randomized controlled trial
- Who was studied
- 7,447 participants at high cardiovascular risk in the PREDIMED trial
- What was measured
- All-cause mortality
THE PAPER
Polyphenol intake and mortality risk: a re-analysis of the PREDIMED trial.
Tresserra-Rimbau A, Rimm EB, Medina-Remón A, Martínez-González MA, López-Sabater MC, Covas MI, Corella D, Salas-Salvadó J, Gómez-Gracia E, Lapetra J, Arós F, Fiol M, Ros E, Serra-Majem L, Pintó X, Muñoz MA, Gea A, Ruiz-Gutiérrez V, Estruch R, Lamuela-Raventós RM, PREDIMED Study Investigators. BMC Med, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.